Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MIMEDX GROUP, INC.MDXG · Entity 5271 | Director · Chief Executive Officer | June 09, 2022 | June 13, 2022 |
| Protagenic Therapeutics, Inc.\newPTIX · Entity 8496 | Director | March 25, 2024 | April 02, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MIMEDX GROUP, INC.
Report date June 09, 2022 · Filed June 13, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,711,324 |
Reported balance
After 2022-06-09 transaction · row 1
1 source rowRow 1 · 2022-06-09 · Sale · Disposed 112,000 · Balance 1,711,324 F1: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting.
Protagenic Therapeutics, Inc.\new
Report date March 25, 2024 · Filed April 02, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| PTIX Common stock OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $1.74 · Expires 2034-03-25 | Direct | 21,250 |
Reported balance
After 2024-03-25 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-03-25 · Grant · Acquired 21,250 · Balance 21,250 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 25, 2024 Filed Apr 2, 2024 01:41 UTC | Protagenic Therapeutics, Inc.\new PTIX · Entity 8496 | GrantPTIX Common stock Options · Derivative | 21,250 | $1.74 Strike: $1.74 | $36,975.00 |
DisclosureSEC source: 0001493152-24-012598 · ownership.xml · derivative · entry 1 WRIGHT TIMOTHY R · CIK 0001288245 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,250 Underlying: PTIX Common Stock, Par Value $0.0001 · 21,250 shares Expires 2034-03-25 Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 22:45 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 112,000 | $3.75 | $420,000.00 |
DisclosureSEC source: 0001288245-22-000004 · wf-form4_165516028485064.xml · nonDerivative · entry 1 WRIGHT TIMOTHY R · CIK 0001288245 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,711,324 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. Read SEC document |
| April 08, 2022 Filed Apr 12, 2022 21:30 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 602,679 | $4.62 | $2,784,376.98 |
DisclosureSEC source: 0001376339-22-000045 · wf-form4_164979900285144.xml · nonDerivative · entry 1 WRIGHT TIMOTHY R · CIK 0001288245 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,823,324 F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Grant is exempt under Rule 16b-3. Read SEC document |
| March 08, 2022 Filed Mar 10, 2022 21:31 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 45,611 | $4.86 | $221,623.85 |
DisclosureSEC source: 0001376339-22-000027 · wf-form4_164694786510802.xml · nonDerivative · entry 1 WRIGHT TIMOTHY R · CIK 0001288245 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,220,645 F1 · shares: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.75 to $4.965, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| February 23, 2022 Filed Feb 25, 2022 22:11 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 61,000 | $4.31 | $263,074.70 |
DisclosureSEC source: 0001288245-22-000002 · wf-form4_164582706702923.xml · nonDerivative · entry 1 WRIGHT TIMOTHY R · CIK 0001288245 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,266,256 F1 · kind: The reported shares were sold in connection with the vesting of a previously granted restricted stock unit award, as required by company policy, with proceeds being used to cover the Reporting Person's tax withholding liability in connection with the vesting. F2 · price: The sale price indicated is a weighted average sale price. The corresponding shares were sold in multiple transactions at prices ranging from $4.26 to $4.455, inclusive. The reporting person undertakes to provide to MiMedx Group, Inc., any security holder of MiMedx Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 20:09 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | SaleCommon Stock | 101,957 | $0.00 | $0.00 |
DisclosureSEC source: 0001288245-21-000006 · wf-form4_162326935875542.xml · nonDerivative · entry 1 WRIGHT TIMOTHY R · CIK 0001288245 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,327,256 F1 · shares: Reflects sale of shares to cover tax withholding obligation upon vesting of previously-granted award. F2 · price: The 101,957 shares were sold through separate trades, with the sale prices ranging from $10.45 to $11.05, and a weighted average sale price of $10.685. The Reporting Person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate purchase price. Read SEC document |
| March 04, 2021 Filed Mar 8, 2021 21:11 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 335,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001288245-21-000004 · wf-form4_161523785733506.xml · nonDerivative · entry 1 WRIGHT TIMOTHY R · CIK 0001288245 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,429,213 F1 · shares: Reflects grant of restricted stock units which will be settled in common stock following vesting. Award vests pro rata annually over three years. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 19:30 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 70,200 | $9.81 | $688,662.00 |
DisclosureSEC source: 0001288245-21-000002 · wf-form4_161402220618839.xml · nonDerivative · entry 1 WRIGHT TIMOTHY R · CIK 0001288245 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,094,060 F1 · kind: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock. Read SEC document |
| August 05, 2020 Filed Aug 6, 2020 20:49 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 572,033 | $0.00 | $0.00 |
DisclosureSEC source: 0001288245-20-000002 · wf-form4_159674690960654.xml · nonDerivative · entry 1 WRIGHT TIMOTHY R · CIK 0001288245 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,164,260 F1 · price: On August 5, 2020, the Company fixed the number of shares subject to previously-awarded restricted units based on the closing stock price on that date ($5.90). Award will be settled in common stock upon vesting. One-third of the award vests upon each anniversary of the original grant date, February 18, 2020. Grant is exempt under rule 16b-3. Read SEC document |
| June 07, 2020 Filed Jun 9, 2020 13:15 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | Tax withholdingCommon Stock | 89,591 | $3.50 | $313,568.50 |
DisclosureSEC source: 0001376339-20-000035 · wf-form4_159170849467642.xml · nonDerivative · entry 1 WRIGHT TIMOTHY R · CIK 0001288245 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 592,227 F1 · kind: This transaction represents the netting of shares to satisfy applicable witholding taxes upon the vesting of previously-granted restricted stock. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 20:27 UTC | MIMEDX GROUP, INC. MDXG · Entity 5271 | GrantCommon Stock | 681,818 | $4.95 | $3,374,999.10 |
DisclosureSEC source: 0001376339-19-000020 · wf-form4_156028484289894.xml · nonDerivative · entry 1 WRIGHT TIMOTHY R · CIK 0001288245 · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 681,818 F1 · kind: Represents grant of restricted stock which vests one-third on each anniversary. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.